Minimal Residual Disease in Transplant Ineligible Myeloma Patients: Results from the UK NCRI Myeloma XI trial
de Tute, R., Rawstron, A.C., Cairns, D., Pawlyn, C., Davies, F., Collett, C., Jones, J., Kaiser, M., Chalmers, A., Striha, A., Cook, G., Russell, N., Drayson, M.T., Gregory, W.M., Jackson, G.H., MorgaVolume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.07.239
Date:
September, 2015
File:
PDF, 170 KB
english, 2015